Regardless of indication or type, pancreatectomy with AR is associated with risks greater than standard resections. Mortality has decreased in the modern era; however, morbidity remains high from hemorrhagic, fistula, or ischemia-related complications. Mitigation measures are needed if advanced resections are considered with increasing frequency given the potential oncologic benefit of AR in selected cases after modern chemotherapy.
No takes yet. Share an insight, caveat, or question.
Tee et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: